Vetoquinol Sa operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other
pharmaceutical manufacturers in Europe:
sales of 218.30 million Euro [US$269.17 million]
Recipharm AB (publ)
(5.33 billion Swedish Kronor [US$658.60 million]
Dechra Pharmaceuticals PLC
based in the United Kingdom
(£359.28 million [US$503.19 million]
of which 63%
was European Pharmaceuticals).
During the year ended December of 2017, sales at
Vetoquinol Sa were 352.20 million Euro (US$434.28 million).
a very small
increase of 0.5%
versus 2016, when the company's sales were 350.35 million Euro.
This was the fifth consecutive year of sales increases at Vetoquinol Sa
(and since 2012, sales have increased a total of 18%).